Pfizer announced that in patients with established heart disease, Lipitor 80 mg not only significantly reduced the relative risk of suffering a first cardiovascular event by 19 percent compared to Lipitor 10 mg ...
164867 items (164867 unread) in 46 feeds
World Health Organization
(462 unread)
Media
(128004 unread)
Bird Flu
(3515 unread)
Diabetes
(5648 unread)
Cholesterol
(2462 unread)
Cancer
(11808 unread)
HIV
(7247 unread)
Women
(4402 unread)
Men
(1319 unread)
Cholesterol (100 unread)
Pfizer announced that in patients with established heart disease, Lipitor 80 mg not only significantly reduced the relative risk of suffering a first cardiovascular event by 19 percent compared to Lipitor 10 mg ...
New data have not relieved concerns about a possible cancer risk among users of Vytorin.
' The news hit this week that a cholesterol-lowering drug called Vytorin was linked to a possible risk of cancer.
A House committee investigating the safety and effectiveness of the popular cholesterol drug Vytorin and one of its components is turning up the heat on the drug's makers.
Understanding cholesterol is more than figuring out what's good and bad. Although much is known about this waxy substance that's in all body cells and its relationship with heart disease, much is still ...
New research finds no definitive link between Vytorin and cancer risk, but it also suggests that the cholesterol-lowering drug cannot curb cardiovascular disease.
CHICAGO - Older people who have had a stroke or mini-stroke benefit from cholesterol-lowering statin drugs just as much as younger people do, U.S. researchers said on Wednesday."Even though the majority of ...
Taking a cholesterol-lowering drug after a stroke or mini-stroke reduces an older person's risk of another stroke much as it does in younger patients, according to a U.S. study.
Epidemiologists have cleared a class of cholesterol-lowering drug that had been implicated in a cancer scare.
Heart experts said patients should continue to take an anti-cholesterol drug despite new fears it could cause cancer.
One in three people with a high risk of developing cardiovascular disease over the next 10 years have not been diagnosed, according to a major UK study in the September issue of IJCP, the International Journal ...
Television ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc.
Experts clashed over the safety of Merck & Co and Schering-Plough's cholesterol drug Vytorin on Tuesday as full results from a controversial study were presented at Europe's biggest medical congress.
When the Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical trials covering a total of 3,900 patients.
Giving patients Novartis's anti-cholesterol drug Lescol after major vascular surgery reduces the risk of serious heart problems, researchers said on Monday.
Are all saturated fats bad for you? What about coconut oil? Is it dangerous to heat olive oil? Which is better: polyunsaturated or monounsaturated fat? We asked a few of the country's leading nutrition experts, ...
AstraZeneca welcomes the recommendations by the National Institute for Health and Clinical Excellence on the treatment of Familial Hypercholesterolaemia 1, a genetic condition resulting in high cholesterol ...
New data on whether the popular cholesterol drugs Zetia and Vytorin increase risk of cancer will be one of the highlights of a huge European conference of heart specialists opening Saturday.
Pfizer Inc. said Friday a court in Denmark has blocked Ranbaxy Laboratories from launching a generic version of the blockbuster cholesterol drug Lipitor in that country.
U.S. drug regulators said this week that they were investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer.
PEOPLE who are tempted to quit taking their statin medication because it failed to prevent a heart attack should think twice, Canadian researchers said on Wednesday.
Dear Dr. Gott: I am a 76-year-old male. I am 6 feet tall and weigh 175 pounds. My blood pressure ranges from 109 to 125/56 to 68, with a pulse between 44 and 53.
Dear Dr. Gott: In a past column, you recommended replacing Lipitor with either omega-3 fish oil capsules or niacin.
Never mind expensive drugs or new-fangled margarines, scientists say they have devised a simple diet that dramatically reduces cholesterol without any need for medication Never mind expensive drugs or ...
No Prescription Required 08.25.08 [ edit ] Atorvastatina is the generic alternative to Lipitor that helps reduce the chances of heart attack, and stoke.
What's in your children's health future? Strong evidence indicates that if your child is overweight, heart disease may be a part of their future.
Australian health authorities say they will review new information raising possible safety concerns about a popular cholesterol-lowering medication.
TRENTON, N.J. -- A congressional committee is giving the two makers of the cholesterol drug Vytorin two weeks to produce extensive data on a clinical study indicating the drug might increase the risk of cancer.
Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.
LifeCycle Pharma A/S announced today that the royalty stream in North America related to its first commercialized product, Fenoglide , the cholesterol lowering drug for the treatment of hyperlipidemia and ...
Researchers who last year reported a possible link between cholesterol-lowering statin drugs and cancer now say that further analysis has disproved such an association.
Nicole Martin did everything right when it came to controlling her cholesterol. She avoided red meat and food loaded with saturated fat and instead opted for lots of heart-healthy oatmeal and whole grains.
"Oh, you're not obese.' You're just sick! Here, take this pill." Rather than getting grilled by your doctor over eating habits, exercise schedules and caloric intake, Big Pharma has found a way to rake in ...
NEW YORK If you think that marketing in the drug category is becoming less interesting and more monotonous, you're right.
Abbott and AstraZeneca announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR , a medication used along with diet to reduce high cholesterol.
If you think that marketing in the drug category is becoming less interesting and more monotonous, you're right.
Dear Dr. Donohue: I have what may be an unusual cholesterol problem -- not enough of it.
Egg whites have become very popular due to their high protein and low cholesterol content.
A small but growing percentage of British Columbians who take statins to lower their cholesterol have twigged to the fact that they can save on their medication bills by pill splitting, a new study suggests.
As proposed buyouts sweep through the drug sector, Pfizer's failure in recent years to buy another big rival has surprised many investors, some of whom say its too late for a big acquisition to rescue the No.
An unorthodox way to lower "bad" cholesterol by suppressing a liver protein may soon challenge statins for the cholesterol-drug crown.
Q: I was on Lipitor for a number of years and have severe muscle and nerve damage to the extent that I am in a power wheelchair.